Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 2
Submit an article Journal homepage
984
Views
23
CrossRef citations to date
0
Altmetric
Letter to the Editor

Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR T-cell therapy

Nasheed M. Hossaina Division of Blood & Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA; ORCID Iconhttps://orcid.org/0000-0002-3278-655XView further author information
ORCID Icon,
Saurabh Dahiyab Blood and Marrow Transplant Program, University of Maryland Medical Center, Baltimore, MD, USA; View further author information
,
Ryan Lec Irvine School of Medicine, University of California, Irvine, CA, USAView further author information
,
Armen M. Abramiana Division of Blood & Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA; View further author information
,
Katherine A. Konga Division of Blood & Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA; View further author information
,
Lori S. Mufflya Division of Blood & Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA; View further author information
&
David B. Miklosa Division of Blood & Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA; Correspondence[email protected]
View further author information
 show all
Pages 503-506 | Received 22 Dec 2017, Accepted 06 May 2018, Published online: 03 Jul 2018

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Miaomiao Li, Ning Ding, Lan Mi, Yunfei Shi, Xinhua Du, Yuting Yi, Ling Yang, Weiping Liu & Jun Zhu. (2022) Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients. Leukemia & Lymphoma 63:3, pages 608-617.
Read now
Piers Blombery & Sarah-Jane Dawson. (2019) Circulating tumor DNA for disease monitoring in the era of CAR T-cell therapy. Leukemia & Lymphoma 60:2, pages 279-280.
Read now

Articles from other publishers (21)

Victor Tomacinschii, Adrian Mosquera Orgueira, Carlos Aliste Santos, Maria Robu, Sanda Buruiana & Maximo Francisco Fraga Rodriguez. (2023) The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. Frontiers in Oncology 13.
Crossref
Erin A. Dean, Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed M. Hossain, Michael D. Jain, Saurabh Dahiya, David B. Miklos, Philipp M. Altrock & Frederick L. Locke. (2023) Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances 7:16, pages 4608-4618.
Crossref
Maroun Bou Zerdan, Joseph Kassab, Ludovic Saba, Elio Haroun, Morgan Bou Zerdan, Sabine Allam, Lewis Nasr, Walid Macaron, Mahinbanu Mammadli, Sarah Abou Moussa & Chakra P. Chaulagain. (2023) Liquid biopsies and minimal residual disease in lymphoid malignancies. Frontiers in Oncology 13.
Crossref
Hao Xu, Ningwen Li, Gaoxiang Wang & Yang Cao. (2023) Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B-cell lymphomas. Frontiers in Immunology 14.
Crossref
Giovanni Manfredi Assanto, Ilaria Del Giudice, Irene Della Starza, Roberta Soscia, Marzia Cavalli, Mattia Cola, Vittorio Bellomarino, Mariangela Di Trani, Anna Guarini & Robin Foà. (2023) Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?. Frontiers in Oncology 13.
Crossref
Rafael Colmenares, Noemí Álvarez, Santiago Barrio, Joaquín Martínez-López & Rosa Ayala. (2022) The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies. Cancers 14:5, pages 1310.
Crossref
Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, Mark Sementsov, Isabel Heidrich, Christoffer Gebhardt, Laura Keller & Klaus Pantel. (2022) Current and Future Clinical Applications of ctDNA in Immuno-Oncology. Cancer Research 82:3, pages 349-358.
Crossref
Aaron M. Goodman, Kimberly A. Holden, Ah-Reum Jeong, Lisa Kim, Kerry D. Fitzgerald, Eyad Almasri, Graham McLennan, Marcia Eisenberg, Amin H. Jahromi, Carl Hoh, Michael Hurley, Carolyn Mulroney, Dimitrios Tzachanis, Edward D. Ball, Taylor J. Jensen & Razelle Kurzrock. (2022) Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy 28:1, pages 30.e1-30.e7.
Crossref
Eliza A. Hawkes, Tycel Phillips, Lihua Elizabeth Budde, Armando Santoro, Nakhle S. Saba, Fernando Roncolato, Gareth P. Gregory, Gregor Verhoef, Fritz Offner, Cristina Quero, John Radford, Krzysztof Giannopoulos, Don Stevens, Aron Thall, Bo Huang, A. Douglas Laird, Robin Sandner & Stephen M. Ansell. (2021) Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study. Targeted Oncology 16:6, pages 761-771.
Crossref
Matthew J. Frank, Nasheed M. Hossain, Ali Bukhari, Erin Dean, Jay Y. Spiegel, Gursharan K. Claire, Ilan Kirsch, Allison P. Jacob, Chelsea D. Mullins, Lik Wee Lee, Katherine A. Kong, Juliana Craig, Crystal L. Mackall, Aaron P. Rapoport, Michael D. Jain, Saurabh Dahiya, Frederick L. Locke & David B. Miklos. (2021) Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology 39:27, pages 3034-3043.
Crossref
Gloria Iacoboni, Marc Simó, Guillermo Villacampa, Eva Catalá, Cecilia Carpio, Cándido Díaz-Lagares, Ángela Vidal-Jordana, Sabela Bobillo, Ana Marín-Niebla, Ana Pérez, Moraima Jiménez, Pau Abrisqueta, Francesc Bosch & Pere Barba. (2021) Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy. Annals of Hematology 100:9, pages 2303-2310.
Crossref
Edward Poynton & Jessica Okosun. (2021) Liquid biopsy in lymphoma: Is it primed for clinical translation?. eJHaem 2:3, pages 616-627.
Crossref
Elodie Bohers, Pierre-Julien Viailly & Fabrice Jardin. (2021) cfDNA Sequencing: Technological Approaches and Bioinformatic Issues. Pharmaceuticals 14:6, pages 596.
Crossref
Rahul Lakhotia & Mark Roschewski. (2021) Circulating tumour DNA in B‐cell lymphomas: current state and future prospects. British Journal of Haematology 193:5, pages 867-881.
Crossref
Giulia Regazzo, Francesco Marchesi, Manuela Spagnuolo, Ana Belén Díaz Méndez, Serena Masi, Andrea Mengarelli & Maria Giulia Rizzo. (2021) Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?. Blood Reviews 47, pages 100776.
Crossref
Xiangyu Tan, Han Yan, Lei Chen, Yuyang Zhang & Chunyan Sun. (2021) Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis. Frontiers in Oncology 11.
Crossref
Darel Martínez Bedoya, Valérie Dutoit & Denis Migliorini. (2021) Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma. Frontiers in Immunology 12.
Crossref
Pierre Heimann & Laurent Dewispelaere. (2020) Indications of next-generation sequencing in non-Hodgkin's lymphoma. Current Opinion in Oncology 32:5, pages 391-397.
Crossref
Vincent Camus & Fabrice Jardin. (2019) Cell-free DNA and the monitoring of lymphoma treatment. Pharmacogenomics 20:18, pages 1271-1282.
Crossref
Sara Galimberti, Elisa Genuardi, Francesco Mazziotta, Lorenzo Iovino, Fortunato Morabito, Susanna Grassi, Elena Ciabatti, Francesca Guerrini & Mario Petrini. (2019) The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice. Frontiers in Oncology 9.
Crossref
Rachel Hu, Allison Winter & Brian T. Hill. (2019) The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma. Current Oncology Reports 21:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.